Skip to Content Facebook Feature Image

Manulife and Bupa Sign MoU for Strategic Collaboration in Hong Kong to Create a More Robust, Integrated Healthcare Network Offering Customers Greater Access and Choice

Business

Manulife and Bupa Sign MoU for Strategic Collaboration in Hong Kong to Create a More Robust, Integrated Healthcare Network Offering Customers Greater Access and Choice
Business

Business

Manulife and Bupa Sign MoU for Strategic Collaboration in Hong Kong to Create a More Robust, Integrated Healthcare Network Offering Customers Greater Access and Choice

2025-12-15 13:45 Last Updated At:14:05

HONG KONG, Dec. 15, 2025 /PRNewswire/ -- Manulife (International) Limited ("Manulife") and Bupa International Limited ("Bupa") are pleased to announce today the signing of a Memorandum of Understanding ("MoU"), intended to establish a strategic collaboration in Hong Kong that will provide customers with greater convenience and flexibility in managing their health.

United by a shared commitment to enhancing healthcare and wellbeing for the people of Hong Kong, this proposed strategic collaboration will combine the strengths of two industry leaders to build a more robust and integrated healthcare network for their customers. Under the signed MoU, Manulife and Bupa intend for customers to benefit from expanded access to high-quality care, greater convenience, enhanced value and affordability through integrated healthcare solutions and personalised support at every stage of their healthcare journey.

 

"This strategic collaboration marks a significant milestone in our ambition to be the health partner of choice, driving better value and health outcomes for our customers," said Patrick Graham, CEO of Manulife Hong Kong and Macau. "As people live longer and aspire to healthier, more purposeful lives, we see an increasing need for a connected healthcare ecosystem that ensures longevity goes hand in hand with quality of life. By combining our strengths with Bupa, this strategic collaboration will offer greater choice and sustainable healthcare solutions that empower individuals and communities to live healthier and more fulfilling lives. This also underscores our commitment to addressing the needs of a society with a rapidly aging population and shaping a future where healthcare is more accessible and affordable."

Fiona Harris, Managing Director of Bupa Hong Kong, said, "Collaborations are more important than ever as we work together to deliver the connected healthcare ecosystem that enables each consumer to achieve their best health outcome. By joining forces, we can reach more of the people of Hong Kong, introducing new innovations and creating more opportunities through embracing the era of digital health and AI. Together, we are dedicated to delivering future ready, customer first, individualised healthcare solutions."

She added, "At Bupa, our purpose is to help people live longer, healthier, happier lives and make a better world, and this strategic collaboration is a powerful step forward in fulfilling that commitment."

This strategic collaboration will benefit both customers and our businesses. We will share further updates in due course on how this strategic collaboration will continue to strengthen and grow.

About Manulife Hong Kong

Manulife Hong Kong has been a trusted name for more than 125 years. Since our operations started in Asia in 1897, we have grown to become one of the top-tier providers of financial services, offering a diverse range of protection and wealth products and services to over 2.6 million customers in Hong Kong and Macau. We are committed to helping make decisions easier and lives better for our customers.

Manulife Hong Kong, through Manulife International Holdings Limited, owns Manulife (International) Limited, Manulife Investment Management (Hong Kong) Limited, and Manulife Provident Funds Trust Company Limited. These entities are all subsidiaries of Manulife Financial Corporation.

About Manulife

Manulife Financial Corporation is a leading international financial services provider, helping our customers make their decisions easier and lives better. With our global headquarters in Toronto, Canada, we operate as Manulife across Canada, Asia, and Europe, and primarily as John Hancock in the United States, providing financial advice and insurance for individuals, groups and businesses. Through Manulife Wealth & Asset Management, we offer global investment, financial advice, and retirement plan services to individuals, institutions, and retirement plan members worldwide. At the end of 2024, we had more than 37,000 employees, over 109,000 agents, and thousands of distribution partners, serving over 36 million customers. We trade as 'MFC' on the Toronto, New York, and the Philippine stock exchanges, and under '945' in Hong Kong.

Not all offerings are available in all jurisdictions. For additional information, please visit manulife.com.

About Bupa Group

Established in 1947, Bupa's purpose is helping people live longer, healthier, happier lives and making a better world. We are an international healthcare company serving over 60 million customers worldwide. With no shareholders, we reinvest profits into providing more and better healthcare for the benefit of current and future customers. Bupa has businesses around the world, principally in Australia, the UK, Spain, Poland, Chile, Hong Kong SAR, India, Türkiye, Brazil, Mexico and New Zealand. We also have associate businesses in Saudi Arabia.

Bupa (Asia) Limited, a subsidiary of Bupa, has been a health insurance specialist in Hong Kong since 1976, offering one-stop solutions across domestic and international health insurance, and healthcare services. Our comprehensive medical insurance schemes are tailored to meet individual needs, and we provide health solutions for companies of all sizes. We also have a team of registered nurses, health management professionals, and doctors who provide various expert healthcare support.

Our healthcare provision arm, Quality HealthCare Medical Services (QHMS), became part of Bupa Group in October 2013. QHMS offers Western Medicine, Traditional Chinese Medicine, Diagnostics & Imaging, Physiotherapy, Mental Health and Wellness services via a network of over 1,650 provider service points in Hong Kong.

For more information, visit www.bupa.com.hk/en/.

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

Manulife and Bupa Sign MoU for Strategic Collaboration in Hong Kong to Create a More Robust, Integrated Healthcare Network Offering Customers Greater Access and Choice

Manulife and Bupa Sign MoU for Strategic Collaboration in Hong Kong to Create a More Robust, Integrated Healthcare Network Offering Customers Greater Access and Choice

Manulife and Bupa Sign MoU for Strategic Collaboration in Hong Kong to Create a More Robust, Integrated Healthcare Network Offering Customers Greater Access and Choice

Manulife and Bupa Sign MoU for Strategic Collaboration in Hong Kong to Create a More Robust, Integrated Healthcare Network Offering Customers Greater Access and Choice

HANOI, Vietnam, Dec. 15, 2025 /PRNewswire/ -- As Vietnam's rubber and plastic products sector surges with 24.9% annual growth in 2024 and tire production exceeding 30 million units annually—90% destined for export markets—P.S.P. Specialties Public Company Limited, Thailand's leading specialty oils manufacturer with over 30 years of expertise, is expanding into Vietnam's dynamic manufacturing landscape with specialized process oil solutions. The market entry capitalizes on Vietnam's emergence as the world's second-largest footwear exporter with USD 22.9 billion in exports and the tire industry projected to reach 52 million units by 2033, and the country's USD 188 million industrial rubber market growing at 4.02% CAGR through 2028—creating unprecedented demand for high-performance process oils.

Capitalizing on Vietnam's Rubber Manufacturing Leadership
Mr. Sakesan Krongphanich, Deputy Chief Executive Officer of P.S.P. Specialties Public Company Limited, emphasized Vietnam's strategic importance. "Vietnam has emerged as a dominant force in Southeast Asia's rubber manufacturing sector. The convergence of world-class tire production, leading footwear manufacturing, and expanding industrial applications creates exceptional opportunities for specialized process oil solutions," said Mr. Sakesan.

Three Strategic Market Segments
Tire Manufacturing: Vietnam's tire manufacturers produce over 30 million units annually, with exports forecast to reach 52 million units by 2033. Major facilities require consistent supplies of aromatic, naphthenic, and TDAE process oils.

Industrial Rubber: Vietnam's market serves automotive components, construction materials, and electronics manufacturing with growing demand for specialized process oils.

Footwear Industry: With 2,200 footwear companies producing USD 22.9 billion exports in 2024, Vietnam serves global brands. Process oils provide flexibility, durability, and surface finish quality demanded internationally.

Comprehensive Product Portfolio
PSP Specialties offers solutions tailored to Vietnamese manufacturing: Aromatic Process Oils deliver compatibility with natural rubber for tire manufacturing. Naphthenic Process Oils provide Low-PAHs content meeting EU directives. TDAE represents non-carcinogenic alternatives aligning with Vietnam's Extended Producer Responsibility regulations implemented April 2024.

Competitive Advantages
PSP Specialties brings 44 million liters of annual rubber process oil capacity with 45% market share in Thailand, leading global and local tire manufacturers. Strategic facilities in Thailand and Myanmar enable efficient logistics. The company plans to introduce bio-based process oils by mid-2026.

Supporting Sustainable Manufacturing
"Vietnamese manufacturers increasingly face sustainability and environmental requirements from European buyers," Mr. Sakesan emphasized. "Our Low-PAHs, non-carcinogenic process oils meet European Union standards while maintaining superior performance."

"PSP Specialties is committed to becoming a trusted partner for Vietnam's rubber manufacturing industry," Mr. Sakesan concluded. "We provide technical consultation that enables manufacturers to optimize production efficiency and meet international standards." 

About P.S.P. Specialties Public Company Limited
P.S.P. Specialties Public Company Limited (PSP), listed on the Stock Exchange of Thailand, is a leading specialty oils manufacturer with over 30 years of experience and more than 300 specialized formulations serving industrial applications worldwide. For more information: https://specialtyoils.psp.co.th

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

Thai Specialty Oils Leader Targets Vietnam's Booming Tire and Rubber Manufacturing Sector with High-Performance Process Oil Solutions

Thai Specialty Oils Leader Targets Vietnam's Booming Tire and Rubber Manufacturing Sector with High-Performance Process Oil Solutions

Recommended Articles